Ca. Maurer et al., Apoptosis inhibiting factor Bcl-x(L) might be the crucial member of the Bcl-2 gene family in colorectal cancer, DIG DIS SCI, 43(12), 1998, pp. 2641-2648
Since the role of the Bcl-2 gene family has been only poorly investigated i
n colorectal cancer, we have examined the expression of the apoptosis block
ers Bcl-x(L) and Bcl-2, as well as the proapoptotic factors Bax and Bak. No
rthern blot analysis and immunohistochemistry were performed on normal and
cancerous colonic tissue from 12 patients. In colorectal cancer, Bcl-x(L) i
mmunoreaction was stronger than in normal controls, and 83% of the cancers
had increased Bcl-x(L) mRNA expression. The median densitometric Bcl-x(L) v
alues were 3.4-fold higher in carcinomas (P < 0.005). In contrast to the no
rmal colon, colorectal carcinomas often lack any Bcl-2 immunostaining, and
Eel-2 mRNA was not detectable by Northern blots either. Bar was not obvious
ly altered in colorectal cancer, either at the protein level or at the mRNA
level compared to the normal control colon. Bak mRNA expression exhibited
a wide variation in carcinomas, but was somewhat decreased in comparison to
the controls. Of these members of the Eel-2 gene family, Bcl-x(L) seems to
play a major role in colorectal tumori genesis and disease progression. An
agonistic effect might have caused the tendency for reduced Bak expression
. The Bcl-2/Bax regulation system of cell homeostasis seems to be of lesser
importance.